Recent Finacing
Recent Raise
Mnemosyne Pharmaceuticals is a Providence-based biotech developing subunit-selective NMDA receptor modulators (SNRMs) as small-molecule therapeutics for schizophrenia, Rett syndrome and other neuropsychiatric indications, using a partnership-focused discovery platform.
